Screening and Phenotyping of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction .
NCT07082400 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-07-24
Summary
Left-sided heart failure (HF) is known to cause pulmonary hypertension (PH), but the development and severity of PH in HF is highly variable, and contributing factors are not fully understood. Pulmonary hypertension (PH) due to left heart disease (PH-LHD) is a growing health problem with high morbidity and mortality . PH-LHD is the most frequent subset of PH, resulting from left ventricular (LV) dysfunction (systolic and/or diastolic) and/or valvular heart disease (VHD) . Although initial studies focused on patients with reduced left ventricular ejection fraction (EF) , early isolated case reports and more recent case series have shown that PH can occur in heart failure with preserved ejection fraction (HFpEF). There is now growing appreciation that PH is common and may be severe in elderly patients with HFpEF . However, the true prevalence and severity of PH in HFpEF from the general community remain unknown. Previous studies were limited by selection bias, and population-based data have, to date, been lacking. Common to left ventricular failure regardless of EF, increased left-sided filling pressure leads to pulmonary venous hypertension (HTN) and post-capillary PH. In the presence of preserved systolic function, the development of pulmonary venous HTN is associated with the severity of left ventricular diastolic dysfunction, as has been shown in patients with aortic stenosis and normal EF. Beyond this post-capillary contribution to PH, a reactive increase in pulmonary arterial tone or intrinsic arterial remodeling can result in a superimposed pre-capillary component of pulmonary arterial HTN. This has been shown to occur in patients with mitral stenosis and HF with reduced EF. In HFpEF without valvular disease, however, the relative contributions of these pre- and post-capillary components to PH are unclear. Pulmonary arterial compliance (CPA) is a predictor of prognosis in patients with SHF, irrespective of pulmonary vascular resistance (PVR).Recently, at the fifth World Symposium on Pulmonary Hypertension in Nice, France, in 2013, two subsets of PH-LHD (post-capillary PH) were defined as isolated post-capillary PH (Ipc-PH; diastolic pulmonary vascular pressure gradient \[DPG\] \< 7 mm Hg, previously labeled as "passive" PH-LHD) and combined pre- and post-capillary PH (Cpc-PH; DPG ≥ 7 mm Hg, previously labeled as "out-of-proportion" or "reactive" PH-LHD, because of pulmonary pressures higher than expected from increased pulmonary artery wedge pressure (PAWP). HF therapies such as β-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and spironolactone improve LV function and reduce LV filling pressures, but have not been convincingly shown to improve RV function in humans. In contrast, pulmonary vasodilators that have been approved for the treatment of pulmonary arterial hypertension (PAH) have never demonstrated a benefit in HF populations, including recent randomized trials . There are Diagnostic Dilemmas as diastolic heart failure causing pulmonary hypertension and pulmonary hypertension causing diastolic dysfunction. Chronic right ventricular pressure overload can affect left ventricular diastolic function in several ways. Left ventricular relaxation is under the triple control of load, myocardial properties, and the uniformity of load in space and time .18 In chronic right ventricular pressure overload, the load on the intraventricular septum is dramatically increased and as it hypertrophies, the myocardial properties of the septum are altered. The motion of the intraventricular septum in systole and diastole is asynchronous. All these factors could contribute to impairment in global left ventricular relaxation. In Doppler echocardiographic studies of IPAH, impaired relaxation with decreased E/A ratio and increased isovolumic relaxation time and deceleration time have been consistently reported . While patients must have normal PCWP to be diagnosed with IPAH, there is considerable evidence that chronic right ventricular pressure overload can cause reduced left ventricular compliance. The external forces affecting the LV-EDPVR include right ventricular pressure and pericardial pressure.19\_20 The effect of right ventricular pressures on the LV-EDPVR is termed "ventricular interdependence" and is accentuated in the presence of an intact pericardium . These effects were also apparent in chronic right ventricular pressure overload, but a decrease in myocardial compliance (as assessed by the stress-strain relationship) was also seen.
Conditions
- Pulmonary Hypertension
Interventions
- PROCEDURE
-
right heart catheter
measurement of hemodynamics of pulmonary circulation in patients diagnosed with heart failure with preserved ejection fraction
Sponsors & Collaborators
-
Sohag University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-01
- Primary Completion
- 2026-08-01
- Completion
- 2026-08-01
More Related Trials
-
The Use of Advanced Imaging in HFpEF
NCT06905405 ·Status: RECRUITING
-
Hemodynamic Testing Strategies to Assess Pulmonary Hypertension in Heart Failure
NCT05672719 ·Status: UNKNOWN
-
Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF
NCT06228807 ·Status: COMPLETED
-
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation
NCT04343430 ·Status: RECRUITING ·Phase: NA
-
Pulmonary Arteyr Denervation for HF Without PH
NCT06323512 ·Status: COMPLETED
-
Chronic Heart Failure With Preserved Ejection Fraction - COngestion eValuation
NCT05097898 ·Status: RECRUITING ·Phase: NA
-
Value of Intense Phenotyping in Heart Failure With Preserved Ejection Fraction
NCT05479669 ·Status: RECRUITING
-
Risk Factors In Heart Failure Patients With Preserved Ejection Fraction
NCT06487468 ·Status: COMPLETED
-
The Relationship Between Epicardial Fat Tissue and Cardiac Function in HFpEF Patients
NCT05068934 ·Status: COMPLETED
-
Non Invasive Measurement of Cardiac Index by Impedance Cardiography
NCT01607515 ·Status: COMPLETED ·Phase: NA
-
Finding Early Predictors of Myocardial Dysfunction
NCT02026154 ·Status: COMPLETED
-
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
NCT04343443 ·Status: RECRUITING ·Phase: NA
-
Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics
NCT02052804 ·Status: COMPLETED
-
Prediction of the Development of Heart Failure With Preserved Ejection Fraction
NCT04894968 ·Status: UNKNOWN
-
Acute Heart Failure - COngestion Discharge Evaluation
NCT04332692 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of B-Type Natrieutic Peptide (BNP) Levels in Patients With Congenital Heart Disease(BNP)
NCT00308230 ·Status: COMPLETED ·Phase: NA
-
Improving Pulmonary Hypertension Screening by Echocardiography
NCT06038149 ·Status: ACTIVE_NOT_RECRUITING
-
Lung Ultrasoung Guided Treatment in Chronic Heart Failure Patients: a Randomized Controlled Trial
NCT02959372 ·Status: COMPLETED ·Phase: NA
-
Characteristics, Phenotypes, and TRAITS of Heart Failure With Preserved Ejection Fraction (TRAITS-HFpEF)
NCT05383287 ·Status: RECRUITING
-
Heart Failure Evaluation Study
NCT05583513 ·Status: COMPLETED
-
UK Heart Failure With Preserved Ejection Fraction
NCT05441839 ·Status: RECRUITING
-
The Heart Failure With Preserved Ejection Fraction (HFpEF) Pathophysiology Study.
NCT03186833 ·Status: COMPLETED
-
Pathophysiological Mechanisms of Activity-Related Dyspnea in Heart Failure: A Pilot Study
NCT02007486 ·Status: UNKNOWN
-
Clinical Significance and Diagnosis of Sarcopenia in Cardiac Patients
NCT04175080 ·Status: UNKNOWN
-
A Hemodynamically Oriented Echocardiography-Based Strategy in the Treatment of Congestive Heart Failure
NCT00280254 ·Status: TERMINATED ·Phase: PHASE2